CSL Behring

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: -

Employees: -

Market Cap: -

Website: http://www.cslbehring.com/

Clinical Trials

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

Phase 3

Active, not recruiting

Conditions: Dermatomyositis

Interventions: Drug: Placebo
Drug: human immunoglobulin G

First Posted Date: 2019-08-05

Last Posted Date: 2024-07-05

Lead Sponsor: CSL Behring

Target Recruit Count: 126

Registration Number: NCT04044690

Locations: 🇺🇸
8401210 - University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇯🇵
3920125 - Tokyo Medical And Dental University Medical Hospital, Bunkyo, Tokyo, Japan
🇲🇽
4840081 - Centro Integral en Reumatologia, SA de CV, Guadalajara, Jalisco, Mexico

and more 73 locations

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

Phase 1

Completed

Conditions: Hidradenitis Suppurativa
Palmoplantar Pustulosis

Interventions: Biological: Recombinant anti-granulocyte colony-stimulating factor (G-CSF) receptor monoclonal antibody

First Posted Date: 2019-06-03

Last Posted Date: 2023-05-26

Lead Sponsor: CSL Behring

Target Recruit Count: 39

Registration Number: NCT03972280

Locations: 🇦🇺
Holdsworth House Medical Practice, Darlinghurst, Australia
🇦🇺
Fremantle Dermatology, Fremantle, Australia
🇦🇺
Westmead Hospital, Westmead, Australia

and more 8 locations

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

Phase 2

Recruiting

Conditions: Acute-graft-versus-host Disease

Interventions: Biological: Alpha-1 antitrypsin (AAT)
Biological: Placebo

First Posted Date: 2019-01-16

Last Posted Date: 2024-12-10

Lead Sponsor: CSL Behring

Target Recruit Count: 310

Registration Number: NCT03805789

Locations: 🇮🇹
Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Calabria, Italy
🇺🇸
HonorHealth Scottsdale Shea Medical Center, Scottsdale, Arizona, United States
🇺🇸
Johns Hopkins Hospital, Saint Petersburg, Florida, United States

and more 31 locations

Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP

Terminated

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

First Posted Date: 2018-12-19

Last Posted Date: 2021-01-15

Lead Sponsor: CSL Behring

Target Recruit Count: 11

Registration Number: NCT03779828

Locations: 🇫🇷
Hôpital Pellegrin, Bordeaux University Hospital (CHU), Bordeaux, France
🇫🇷
Hôpital Henri Mondor - APHP, Créteil, France
🇫🇷
Hôpital Roger Salengro - CHRU, Lille, France

and more 7 locations

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

Phase 3

Terminated

Conditions: Antibody-mediated Rejection

Interventions: Biological: Clazakizumab
Drug: Physiologic saline solution

First Posted Date: 2018-11-19

Last Posted Date: 2024-04-24

Lead Sponsor: CSL Behring

Target Recruit Count: 194

Registration Number: NCT03744910

Locations: 🇺🇸
Keck Medical Center Of USC, Los Angeles, California, United States
🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Rush University Medical Center - University Cardiovascular Surgeons, Chicago, Illinois, United States

and more 135 locations

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Phase 2

Completed

Conditions: Hereditary Angioedema

Interventions: Drug: Placebo
Biological: Factor XIIa antagonist monoclonal antibody

First Posted Date: 2018-10-19

Last Posted Date: 2022-11-08

Lead Sponsor: CSL Behring

Target Recruit Count: 44

Registration Number: NCT03712228

Locations: 🇺🇸
Donald S. Levy, Orange, California, United States
🇺🇸
Allergy & Asthma Clinical Research, Walnut Creek, California, United States
🇺🇸
The Mount Sinai Hospital, New York, New York, United States

and more 13 locations

Two Dose Levels of Privigen in Pediatric CIDP

Phase 4

Recruiting

Conditions: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Interventions: Biological: IgPro10

First Posted Date: 2018-09-25

Last Posted Date: 2024-12-06

Lead Sponsor: CSL Behring

Target Recruit Count: 30

Registration Number: NCT03684018

Locations: 🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States
🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States

and more 6 locations

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Phase 3

Active, not recruiting

Conditions: Hemophilia B

Interventions: Genetic: AAV5-hFIXco-Padua
Biological: Factor IX (FIX)

First Posted Date: 2018-06-26

Last Posted Date: 2025-01-07

Lead Sponsor: CSL Behring

Target Recruit Count: 67

Registration Number: NCT03569891

Locations: 🇺🇸
University of Texas Health Science Center & Medical School, Houston, Texas, United States
🇺🇸
Bloodworks Northwest, Seattle, Washington, United States
🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States

and more 30 locations

Dose Confirmation Trial of AAV5-hFIXco-Padua

Phase 2

Completed

Conditions: Hemophilia B

Interventions: Genetic: AAV5-hFIXco-Padua (AMT-061)

First Posted Date: 2018-04-05

Last Posted Date: 2024-06-28

Lead Sponsor: CSL Behring

Target Recruit Count: 3

Registration Number: NCT03489291

Locations: 🇺🇸
Phoenix Childrens Hospital, Phoenix, Arizona, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
University of California, Davis, Sacramento, California, United States

and more 1 locations

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

Phase 3

Completed

Conditions: Acute Coronary Syndrome

Interventions: Other: Placebo
Biological: Apolipoprotein A-I [human] (apoA-I)

First Posted Date: 2018-03-22

Last Posted Date: 2024-05-09

Lead Sponsor: CSL Behring

Target Recruit Count: 18200

Registration Number: NCT03473223

Locations: 🇦🇷
0320022 - Hospital El Cruce, Florencio Varela, Argentina
🇦🇺
0360092 - Monash Medical Centre, Clayton, Victoria, Australia
🇺🇸
8400693 - University of California Los Angeles, Los Angeles, California, United States

and more 900 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy